D-0867-2020 Class I Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0867-2020 was initiated by RemedyRepack Inc. on Dec 27, 2019 and is designated Class I. Reason for recall: Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples. The recall status is terminated (terminated Aug 18, 2020). Affected quantity: 75 1 ml vials.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Dec 27, 2019
Termination Date
Aug 18, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
75 1 ml vials

Product description

Ketorolac Trom, 30 mg/1mL Inj. for I.V./I.M. Use, Rx Only, QTY: 1 ml, Repackaged by: RemedyRepack Inc., Indiana, PA 15701 NDC 70518-1239-00

Reason for recall

Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.

Distribution pattern

Product distributed in OK and LA.

Code information

Lot # B0444562-060118, exp. 04/2020, B0537002-112118, exp 07/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0867-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0867-2020. Report a data issue: hello@regdatalab.com.